Ceres Eloah de Lucena Ferretti

Ceres Eloah de Lucena Ferretti

Auto-generated profile, based on publicly available information

Ceres Eloah de Lucena Ferretti

University of São Paulo Medical School, São Paulo Brazil

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CFCeres Ferretti
Ceres Ferretti
Flavia Mori SartiFlavia Mori Sarti
Flavia Mori Sarti
RNRicardo Nitrini
Ricardo Nitrini
FFFernando F Ferreira
Fernando F Ferreira
SBSonia M D Brucki
Sonia M D Brucki
To analyze costs associated with dementia based on a cross-sectional study in the Brazilian health system. Direct and indirect costs were estimated by conducting comprehensive interviews on the use of resources in a sample of 156 patients with dementia treated at an outpatient memory clinic of a tertiary hospital. A regression model was used to determine the main determinants of costs associated with dementia. Global costs of dementia were US$1,012.35; US$1,683.18 and US$1,372.30 per patient/month for mild, moderate and severe stages, respectively. Indirect costs ranged from US$536.62 to US$545.17 according to severity. Dementia costs were influenced by medication, FAST score, and educational level of caregiver. The study represents an original contribution toward establishing direct and indirect costs of dementia in Brazil. Results indicate significant economic impacts, including projection of annual costs of US$16,548.24 per patient.

28 November 2022 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
IAIvan Aprahamian
Ivan Aprahamian
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
VSVictor Calil da Silveira
Victor Calil da Silveira
CFCeres Eloah de Lucena Ferretti
Ceres Eloah de Lucena Ferretti
LMLilian Schafirovits Morillo
Lilian Schafirovits Morillo
RESUMO A doença de Alzheimer (DA) e outras demências neurodegenerativas têm um curso progressivo com comprometimento da cognição, capacidade funcional e comportamento. A maioria dos estudos enfocou a DA. A demência grave está associada ao aumento da idade, maior morbimortalidade e aumento dos custos de cuidados. É fundamental reconhecer que a demência grave é o período mais longo de progressão, com o paciente vivendo muitos anos nesta fase. É a fase mais heterogênea do processo, com diferentes habilidades e expectativa de vida. Esta diretriz de prática concentra-se na demência grave para melhorar o manejo e o cuidado nessa fase da demência. Como um longo período no continuum da demência, as abordagens não farmacológicas e farmacológicas devem ser consideradas. Intervenções multidisciplinares (fisioterapia, fonoaudiologia, nutrição, enfermagem, entre outras) são essenciais, além de educacionais e de apoio aos cuidadores.

1 March 2015 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
PDF file
CFCeres Eloah Lucena Ferretti
Ceres Eloah Lucena Ferretti
RNRicardo Nitrini
Ricardo Nitrini
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
Costs with dementia have been the focus of research around the world and indirect costs to the caregiver appear in the literature as responsible for the greatest impact. In Latin American (LA) studies, indirect costs with dementia range from 60% to 75% of family income.

13 August 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
CFCeres Ferretti
Ceres Ferretti
RNRicardo Nitrini
Ricardo Nitrini
SBSonia M. D. Brucki
Sonia M. D. Brucki
Background: In the last 10 months, due to the Covid-19 pandemic, several studies have shown that health education and virtual support strategies for caregivers of patients with dementia, in the management of home care, can be viable. Low and middle income countries, in particular, have sought to use these means to reduce the daily burden of caregivers, through virtual meetings of education and support.Objectives: To present the feasibility of a pilot study on the use of a support action contemplated by the Caad Project–indirect costs of dementia–from HC-FMUSP.Methods: Observational study in which 93 caregivers were invited to participate in virtual meetings on a frequency of three times/week, lasting 1 h each.Results: Of the 93 invited family members, and after 3 months, 42 answered eight questions about the effectiveness of the action. High percentages of positive responses regarding program satisfaction ranged from 86 to 100%.Conclusion: This study showed results of a very simple intervention that suggests that it is possible to offer caregivers of patients with dementia a program that can be used in primary care, in order to understand the difficulty of caregivers in their daily care of patients with dementia, with daily management guidelines on a case-by-case basis, in addition to promoting the implementation of an education strategy about the importance of knowing, and recognizing anatomophysiological changes in the aging process and its implications for the rupture of the imaginary line that involves senescence and senility. This allows the caregiver to feel able to protect his patient and himself by preventing the emergence of common diseases in this age group. Further studies are needed to explore this type of non-pharmacological support.

1 September 2022 in Dementia & Neuropsychologia
Verified
Journal Article
Open access
SBSonia Maria Dozzi Brucki
Sonia Maria Dozzi Brucki
IAIvan Aprahamian
Ivan Aprahamian
WBWyllians Vendramini Borelli
Wyllians Vendramini Borelli
VSVictor Calil da Silveira
Victor Calil da Silveira
CFCeres Eloah de Lucena Ferretti
Ceres Eloah de Lucena Ferretti
LMLilian Schafirovits Morillo
Lilian Schafirovits Morillo
Alzheimer’s disease (AD) and other neurodegenerative dementias have a progressive course, impairing cognition, functional capacity, and behavior. Most studies have focused on AD. Severe dementia is associated with increased age, higher morbidity-mortality, and rising costs of care. It is fundamental to recognize that severe dementia is the longest period of progression, with patients living for many years in this stage. It is the most heterogeneous phase in the process, with different abilities and life expectancies. This practice guideline focuses on severe dementia to improve management and care in this stage of dementia. As it is a long period in the continuum of dementia, clinical practice should consider non-pharmacological and pharmacological approaches. Multidisciplinary interventions (physical therapy, speech therapy, nutrition, nursing, and others) are essential, besides educational and support to caregivers.

10 November 2026
Verified
Book Chapter
Closed access
PDF file
CFCeres Eloah del Lucena Ferretti
Ceres Eloah del Lucena Ferretti
LVLuciana Araujo Vieira
Luciana Araujo Vieira
As doenças crônicas não transmissíveis, como as que dão origem a diferentes síndromes demenciais, estão em franco crescimento na América Latina. Isso se deve ao aumento da expectativa de vida e, consequentemente, ao crescimento da população idosa nessa região, além do fato de que doenças neurodegenerativas são consideradas idade-dependentes (1,2).